Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 6, 2000, Pages 1422-1431

  Sano, Yoichiro ^a,b   Ksander, Bruce R ^a   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b KYOTO PREFECTURAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGRAFT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORNEA EPITHELIUM; CORNEA TRANSPLANTATION; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; GRAFT REJECTION; HLA MATCHING; LANGERHANS CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ACUTE DISEASE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL MOVEMENT; CORNEAL TRANSPLANTATION; GRAFT REJECTION; H-2 ANTIGENS; HYPERSENSITIVITY, DELAYED; IMMUNITY; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED A; MICE, INBRED BALB C; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034059575     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol. 1997;25:1-54.
2. Niederkorn JY, Peeler JS, Ross J, Callanan D. The immunogenic privilege of corneal allografts. Regional Immunol. 1989;2:117-124.
3. Streilein JW. Immune regulation and the eye: a dangerous compromise. FASEB J. 1987;1:199-208.
4. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol. 1990;48:191-226.
5. Streilein JW, Ksander BR, Taylor AW. Immune deviation in relation to ocular immune privilege. J Immunol. 1997;158:3557-3560.
6. Streilein JW. Immune privilege and the cornea. In: Pleyer U, Hartmann C, Sterry W, editors. Proceedings of Symposium: Bullous oculo-muco-cutaneous disorders. Buren, The Netherlands: Aeolus Press; 1997:43-52.
7. Streilein JW, Bradley D, Sano Y, Sonoda Y. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas. Invest Ophthalmol Vis Sci. 1996;37:413-424.
8. Treseler PA, Foulks GN, Sanfilippo F. The expression of HLA antigens by cells in the human cornea. Am J Ophthalmol. 1984; 98:763-772.
9. Wang HM, Kaplan HJ, Chan WC, Johnson M. The distribution and ontogeny of MHC antigens in murine ocular tissues. Infest Ophthatmol Vis Sci. 1987;28:1383-1389.
10. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189-1192.
11. Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest. 1997;99:396-402.
12. Hori J, Joyce N, Streilein JW. Corneal allografts placed beneath the kidney capsule display inherent immune privilege. Invest Ophthalmol Vis Sci. 2000;41:443-452.
13. Kawashima H, Prasad SA, Gregerson DS. Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production. J Immunol. 1994;153:1982-1989.
14. Donnelly JJ, Xi MS, Rockey JH. A soluble product of human corneal fibroblasts inhibits lymphocyte activation. Enhancement by interferon-gamma. Exp Eye Res. 1993;56:157-165.
15. Streilein JW, Bradley D, Sano Y. Immunosuppressive properties of tissues of the ocular anterior segment. Ocular Immunol Inflam. 1996;4:57-68.
16. Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express Ia antigens. Nature. 1979;282:325-327.
17. Gillette TE, Chandler JW, Greiner JV. Langerhans cells of the ocular surface. Ophthalmology. 1982; 89:700-712.
18. Streilein JW, McCulley J, Niederkorn JY. Heterotopic corneal grafting in mice. A new approach to the study of corneal alloimmunity. Invest Ophthalmol Vis Sci. 1982;23:489-500.
19. Rubsamen PE, McCulley J, Bergstresser PR, Streilein JW. On the Immunogenicity of mouse corneal allografts infiltrated with Langerhans cells. Invest Ophthatmol Vis Sci. 1984;25:513-518.
20. Peeler J, Niederkorn J, Matoba A. Corneal allografts induce cytotoxic T cells but not delayed hypersensitivity responses in mice. Invest Ophthalmol Vis Sci. 1985;26:512-533.
21. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice. Evidence that the immunogenetic rules of rejection do not apply. Transplantation. 1992;54:694-703.
22. Nicholls SM, Bradley BB, Easty DL. Effect of mismatches of major histocompatibility complex and minor antigens on corneal graft rejection. Invest Ophthalmol Vis Sci. 1991;32:2729-2734.
23. Joo C, Pepose JC, Stuart PM. T cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Ophthalmol Vis Sci. 1995;36:1530-1540.
24. Sano Y, Ksander BR, Streilein JW, Minor H. Rather than MHC. alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice. Transplant Immunol. 1996; 4:65-68.
25. Sano Y, Ksander BR, Streilein JW. Murine orthotopic corneal transplantation in "high-risk" eyes. Rejection is dictated primarily by weak rather than strong alloantigens. Invest Ophthalmol Vis Sci. 1997;38:1130-1138.
26. Sonoda Y, Sano Y, Ksander BR, Streilein JW. Characterization of cell mediated immune response elicited by orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci. 1995;36:427-434.
27. Liu, L, Sun YK, Xi YP, et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med. 1993;177: 1643-1650.
28. Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss H. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med. 1994;179:865-872.
29. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today. 1994;15:32-38.
30. Steinmuller D. Immunization with skin isografts taken from tolerant mice. Science. 1967;158:127-129.
31. Lafferty KJ, Prowse SJ, Simeonovic CJ, Warren HS. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol. 1983;1:142-173.
32. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med. 1982;155:31-41.
33. Sano Y, Ksander BR, Streilein JW. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction Invest Ophthalmol Vis Sci. 1995;36: 2176-2185.
34. Williamson JSP, DiMarco S, Streilein JW. Immunobiology of Langerhans cells on the ocular surface. I. Langerhans cells within the central cornea interfere with induction of anterior chamber associated immune deviation. Invest Ophthalmol Vis Sci. 1987;28: 1527-1532.
35. Niederkorn JY, Peeler JS, Mellon J. Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea. Regional Immunol. 1989;2:83-90.
36. Dana MR, Dai R, Yamada J, Streilein JW. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes immune privilege. Invest Ophthalmol Vis Sci. 1998;39:70-77.
37. Ksander BR, Sano Y, Streilein JW. Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes. Transplant Immunol. 1996;4:49-52.
38. Callanan D, Peeler J, Niederkorn JY. Characteristics of rejection of orthotopic corneal allografts in the rat. Transplantation. 1988;45: 437-443.
39. Loveland BE, McKenzie IF. Which T cells cause graft rejection? Transplantation. 1982;33:217-221.
40. Krieger NR, Yin DP, Fathman G. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med. 1996;184:2013-2018.
41. He YG, Ross J, Niederkorn JY. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 antibody. Invest Ophthalmol Vis Sci. 1991;32:2723-2728.
42. Pleyer J, Milani JK, Dukes A, et al. Effect of topically applied anti-CD4 antibodies on orthotopic corneal allografts in a rat model. Invest Ophthalmol Vis Sci. 1995;36:52-61.
43. Williams KA, Ash JK, Coster DJ. Histocompatibility antigen and passenger cell content of normal and diseased human cornea. Transplantation. 1985;39:265-269.
44. Williams KA, Ash JK, Mann TS, Noonan FP, Coster DJ. Cells infiltrating inflamed and vascularized corneas. Transplant Proc. 1987;19:2889-2891.